Catalyst Pharmaceuticals, Inc.CPRXNASDAQ
Loading
EPS Diluted Over TimeExpanding
Percentile Rank100
3Y CAGR+30.8%
5Y CAGR+18.8%
Studio
Year-over-Year Change

Diluted earnings per share

3Y CAGR
+30.8%/yr
Annual compound
5Y CAGR
+18.8%/yr
Recent acceleration
Percentile
P100
Near historical high
vs 5Y Ago
2.4x
Strong expansion
Streak
2 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM1.68+28.2%
20241.31+107.9%
20230.63-16.0%
20220.75+102.7%
20210.37-47.9%
20200.71+136.7%
20190.30+190.9%
2018-0.33-57.1%
2017-0.21+4.5%
2016-0.22-